CDT - Conduit Pharmaceuticals Inc.

CDT - Conduit Pharmaceuticals Inc.

https://www.conduitpharma.com

Recent News

Powered by Alpha Vantage

What's Going On With Conduit Pharmaceuticals Shares Friday? - Conduit Pharmaceuticals ( NASDAQ:CDT )

Benzinga • 5 months ago • score: 0.34

Conduit announced it filed multiple patents related to VTAMA ( tapinarof ) . The company announced it filed multiple patents related to VTAMA. China's new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the next trade alert free.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$274.50

52W Low

$1.16

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.90

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-55.41

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

1.02

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

14.10%

Institutions (25–75% balanced)

0.67%

Shares Outstanding

3,050,300

Float

2,663,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-142.21

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—